AxiTrader Limited
Axi Announces Their Partnership Renewal with Manchester City Star and England International, John Stones
Axi Announces Their Partnership Renewal with Manchester City Star and England International, John Stones
SYDNEY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Axi, a leading force in online Forex and CFD trading, has announced the continuation of its collaboration with Manchester City star and England international John Stones. Having served as the broker’s Global Brand Ambassador since the beginning of the 2023/24 season, Stones will continue to play an important role in representing the Axi brand worldwide.
Hannah Hill, Head of Brand and Sponsorship at Axi, commented: “We are delighted to continue our collaboration with our Brand Ambassador, John Stones. John embodies the winning mentality and drive for excellence that inspires us, and his pursuit of the edge mirrors our own dedication to pushing boundaries and raising the bar to new heights. We’re very excited to build on the success of the past two years and to celebrate even more achievements together.”
With John Stones as Axi’s Global Brand Ambassador and partnerships across three leading football clubs, the broker continues to cement its position as a key player in the sports sponsorship arena. As well as Stones, Axi has been the Official Online Trading Partner of eight-time Premier League Champions, Man City and Man City Women, as well as Brazilian football club, Esporte Clube Bahia and LaLiga club Girona FC, as the club’s Official LATAM Online Trading Partner.
About Axi
Axi is a global online FX and CFD trading brand, with thousands of customers in 100+ countries worldwide. Axi offers CFDs for several asset classes including Forex, Shares, Gold, Oil, Coffee, and more.
For more information or additional comments from Axi, please contact: mediaenquiries@axi.com
Promoted by AxiTrader LLC. OTC Derivatives carry a high risk of investment loss.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG5.11.2025 13:11:23 CET | Press release
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
ROCKWOOL A/S5.11.2025 13:04:11 CET | Press release
ROCKWOOL A/S – transactions in connection with share buy-back programme
Rockwool A/S5.11.2025 13:04:11 CET | Pressemeddelelse
ROCKWOOL A/S – transaktioner i henhold til aktietilbagekøbsprogram
Centessa Pharmaceuticals plc5.11.2025 13:00:00 CET | Press release
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
MoonLake Immunotherapeutics AG5.11.2025 13:00:00 CET | Press release
MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom